Eric J. Forman J.D.
Net Worth

Last updated:

What is Eric J. Forman J.D. net worth?

The estimated net worth of Mr. Eric J. Forman J.D. is at least $940,280 as of 9 Dec 2022. He owns shares worth $356,270 as insider and has received compensation worth at least $584,010 in Lixte Biotechnology Holdings, Inc..

What is the salary of Eric J. Forman J.D.?

Mr. Eric J. Forman J.D. salary is $64,890 per year as Chief Admin. Officer in Lixte Biotechnology Holdings, Inc..

How old is Eric J. Forman J.D.?

Mr. Eric J. Forman J.D. is 45 years old, born in 1980.

What stocks does Eric J. Forman J.D. currently own?

As insider, Mr. Eric J. Forman J.D. owns shares in one company:

Company Title Shares Price per share Total value
Lixte Biotechnology Holdings, Inc. (LIXT) Chief Admin. Officer 102,083 $3.49 $356,270

What does Lixte Biotechnology Holdings, Inc. do?

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.

LIXT logo
LIXT
Lixte Biotechnology Holdings, Inc.
$3.49

Eric J. Forman J.D. insider trading

Lixte Biotechnology Holdings, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 1,112 $0.63 $701
Purchase
Common Stock 2,484 $0.56 $1,391
Purchase
Common Stock 1,457 $0.56 $816
Purchase
Common Stock 2,500 $0.56 $1,400
Purchase
Common Stock 6,059 $0.56 $3,387
Purchase
Common Stock 7,648 $0.57 $4,336
Purchase
Common Stock 4,852 $0.54 $2,620
Option
Common Stock 16,667 $0.9 $15,000
Purchase
Common stock 10,000 $0.3 $3,000
Purchase
Common stock 43,500 $0.3 $12,963
Purchase
Common stock 2,500 N/A N/A

Lixte Biotechnology Holdings key executives

Lixte Biotechnology Holdings, Inc. executives and other stock owners filed with the SEC:

  • Dr. James S. Miser M.D. (77) Chief Medical Officer
  • Dr. John S. Kovach (88) Founder, Pres, Chief Executive Officer, Chief Scientific Officer & Chairman
  • Mr. Eric J. Forman J.D. (45) Chief Admin. Officer
  • Mr. Robert Neal Weingarten (73) Vice President & Chief Financial Officer